フィルフィニッシュ製造の世界市場の評価：製品タイプ別、モダリティ別、エンドユーザー別、地域別、機会、予測（2017年～2031年）

世界のフィルフィニッシュ製造の市場規模は、2023年の117億4,000万米ドルから2031年までに236億8,000万米ドルに達すると予測され、2024年～2031年の予測期間にCAGRで9.17%の成長が見込まれます。市場は近年大幅な成長を示しており、今後も力強い拡大ペースを維持すると予測されます。

フィルフィニッシュ製造では、バイアル、シリンジ、カートリッジ、ボトルなどの一次容器に薬剤を充填します。その後、ラベルを貼り、包装し、シリアルナンバーを付けて、使用と流通の準備を整えます。医薬品に対する需要の増加に対応し、世界中の患者が高品質な処方薬を時間通りに受け取れるようにするためには、フィルフィニッシュ製造施設は効率的かつ一貫して、大規模に稼動する必要があります。生産性を高め、ダウンタイムを減らし、製品の品質と安全性を維持するためには、自動化技術、最先端の製造装置、プロセス最適化技術への投資が必要です。医薬品製造の最終段階であるフィルフィニッシュ製造工程は、患者に医薬品が届けられる前の段階であるため、医薬品需要の増大はこれらの工程に大きな負担を強いています。世界的に慢性疾患や生活習慣病の割合が増加していることから、フィルフィニッシュ製造産業の大幅な成長が予測されています。世界の生物製剤産業の大幅な拡大が、フィルフィニッシュ製造市場の大幅な成長を促進しています。生物製剤は、より効果的で的を絞った治療オプションであるため、現在では従来の医薬品よりも需要が高まっています。さらに、モノクローナル抗体やワクチンの需要の高まりも、フィルフィニッシュ製造工程の増加を後押ししています。さらに、技術の進歩が市場拡大の柱となっています。

例えば、Gerresheimer AGは2023年10月、患者の安全性と生産効率を向上し確保するため、ガラス製注射用バイアルの製品群であるGx Eliteを発表しました。この製品群は主に、衝撃に強く、すぐに割れない、より高品質のバイアルを提供することを重視しています。

医療支出の増加が市場成長を促進

人々が医療のニーズを満たすために医療サービスや治療を求めるようになっていることから、医療費の増加は医療利用の増加と相関しやすいです。医療サービスの需要が増加しているため、さまざまな医療障害の予防、管理、治療に医薬品が使用される頻度が高くなっています。その結果、製薬産業は医薬品の需要の増加に対応するために生産を増やす必要があり、フィルフィニッシュ製造市場に燃料を供給しています。世界的に、がん、糖尿病、心血管疾患、呼吸器疾患などの慢性疾患の有病率が上昇しており、医療費を押し上げています。慢性疾患の長期管理には、症状管理、疾病管理、合併症回避などの医薬品治療が必要です。医薬品に対するニーズは、慢性疾患の管理に重点を置いたシフトによってもたらされており、患者への医薬品の安定供給を保証する効果的なフィルフィニッシュ製造工程が求められています。公共政策、民間投資、国際援助活動の目標は、医療支出を増やし、必要な医療サービスや処方薬へのアクセスを整備し、先進地域や発展途上地域の医療インフラを改善することです。フィルフィニッシュ製造の増加の主な促進要因の1つは、新薬や特殊医薬品の登場です。生物製剤、オーファンドラッグ、精密医薬品は、特定の疾患や複雑な医療需要を抱える患者集団の治療に使用される特殊医薬品の一例です。

このような最先端の治療が安定し、効果を発揮し、製品の完全性を維持するためには、特定のフィルフィニッシュ製造手順が頻繁に必要となります。特殊医薬品の需要に対応するため、製薬企業は製造能力に投資しており、これがフィルフィニッシュ製造市場の成長を後押ししています。例えば、Recro Pharma, Inc.という開発製造受託機関（CDMO）は2022年2月、製造受託サービスのラインナップを拡充し、新たに凍結乾燥機能を追加したと発表しました。同社のフィルフィニッシュ無菌室で自動化された無菌バイアル充填プラットフォームを使い、毎時2,000本の滅菌済みバイアルを充填することができます。このような医療の革新と技術的ブレークスルーは、新しい医療機器、診断、治療法をもたらし、医療費を押し上げています。創薬、遺伝学、医療技術の進歩により、新薬や治療法が開発され、フィルフィニッシュ製造サービスの需要が高まっています。製薬企業は技術開発を利用して新しい医薬品や製剤を開発し、フィルフィニッシュ製造産業に新たな成長の見通しを開いています。フィルフィニッシュ製造ビジネスで競争力を維持するため、製薬企業は規制要件や市場情勢の変化に対応しており、製造インフラや製造能力への投資を増やしています。

当レポートでは、世界のフィルフィニッシュ製造市場について調査分析し、市場規模と予測、市場力学、主要企業の情勢と見通しなどを提供しています。

目次

第1章 調査手法

第2章 プロジェクトの範囲と定義

第3章 エグゼクティブサマリー

第4章 世界のフィルフィニッシュ製造市場の見通し（2017年～2031年）

• 市場規模と予測
  • 金額
  • 数量
• 製品タイプ別
  • 消耗品
  • 器具
• モダリティ別
  • 組み換えタンパク質
  • モノクローナル抗体
  • ワクチン
  • 細胞療法、生物学的療法
  • 遺伝子治療
  • その他
• エンドユーザー別
  • 製造受託企業
  • 製薬企業、バイオ医薬品企業
  • その他
• 地域別
  • 北米
  • 欧州
  • アジア太平洋
  • 南米
  • 中東・アフリカ
• 市場シェア：企業別（2023年）

第5章 世界のフィルフィニッシュ製造市場の見通し：地域別（2017年～2031年）

• 北米
  • 市場規模と予測
  • 製品タイプ別
  • モダリティ別
  • エンドユーザー別
  • 米国
  • カナダ
  • メキシコ
• 欧州
  • ドイツ
  • フランス
  • イタリア
  • 英国
  • ロシア
  • オランダ
  • スペイン
  • トルコ
  • ポーランド
• アジア太平洋
  • インド
  • 中国
  • 日本
  • オーストラリア
  • ベトナム
  • 韓国
  • インドネシア
  • フィリピン
• 南米
  • ブラジル
  • アルゼンチン
• 中東・アフリカ
  • サウジアラビア
  • アラブ首長国連邦
  • 南アフリカ

第6章 市場マッピング（2023年）

• 製品タイプ別
• モダリティ別
• エンドユーザー別
• 地域別

第7章 マクロ環境と産業構造

• 需給分析
• 輸入輸出分析
• バリューチェーン分析
• PESTEL分析
• ポーターのファイブフォース分析

第8章 市場力学

• 成長促進要因
• 成長抑制要因（課題、抑制要因）

第9章 規制枠組みとイノベーション

• 規制当局の承認
• イノベーション/新技術

第10章 主要企業の情勢

• マーケットリーダー上位5社の競合マトリクス
• マーケットリーダー上位5社の市場収益の分析（2023年）
• 合併と買収/合弁事業（該当する場合）
• SWOT分析（市場企業5社）
• 特許分析（該当する場合）

第11章 価格分析

第12章 ケーススタディ

第13章 主要企業の見通し

• Becton, Dickinson and Company
• Nipro Corporation
• Syntegon Technology GmbH
• Datwyler Holding Inc.
• Stevanato Group
• Recro Pharma, Inc.
• Gerresheimer AG
• West Pharmaceutical Services, Inc.
• Alcami Corporation
• Berry Global Inc.

第14章 戦略的推奨

第15章 当社について、免責事項

List of Tables

• Table 1. Pricing Analysis of Products from Key Players
• Table 2. Competition Matrix of Top 5 Market Leaders
• Table 3. Mergers & Acquisitions/ Joint Ventures (If Applicable)
• Table 4. About Us - Regions and Countries Where We Have Executed Client Projects

List of Figures

• Figure 1. Global Fill-Finish Manufacturing Market, By Value, in USD Billion, 2017-2031F
• Figure 2. Global Fill-Finish Manufacturing Market, By Volume, in Million Units, 2017-2031F
• Figure 3. Global Fill-Finish Manufacturing Market Share (%), By Product Type, 2017-2031F
• Figure 4. Global Fill-Finish Manufacturing Market Share (%), By Modality, 2017-2031F
• Figure 5. Global Fill-Finish Manufacturing Market Share (%), By End-user, 2017-2031F
• Figure 6. Global Fill-Finish Manufacturing Market Share (%), By Region, 2017-2031F
• Figure 7. North America Fill-Finish Manufacturing Market, By Value, in USD Billion, 2017-2031F
• Figure 8. North America Fill-Finish Manufacturing Market, By Volume, in Million Units, 2017-2031F
• Figure 9. North America Fill-Finish Manufacturing Market Share (%), By Product Type, 2017-2031F
• Figure 10. North America Fill-Finish Manufacturing Market Share (%), By Modality, 2017-2031F
• Figure 11. North America Fill-Finish Manufacturing Market Share (%), By End-user, 2017-2031F
• Figure 12. North America Fill-Finish Manufacturing Market Share (%), By Country, 2017-2031F
• Figure 13. United States Fill-Finish Manufacturing Market, By Value, in USD Billion, 2017-2031F
• Figure 14. United States Fill-Finish Manufacturing Market, By Volume, in Million Units, 2017-2031F
• Figure 15. United States Fill-Finish Manufacturing Market Share (%), By Product Type, 2017-2031F
• Figure 16. United States Fill-Finish Manufacturing Market Share (%), By Modality, 2017-2031F
• Figure 17. United States Fill-Finish Manufacturing Market Share (%), By End-user, 2017-2031F
• Figure 18. Canada Fill-Finish Manufacturing Market, By Value, in USD Billion, 2017-2031F
• Figure 19. Canada Fill-Finish Manufacturing Market, By Volume, in Million Units, 2017-2031F
• Figure 20. Canada Fill-Finish Manufacturing Market Share (%), By Product Type, 2017-2031F
• Figure 21. Canada Fill-Finish Manufacturing Market Share (%), By Modality, 2017-2031F
• Figure 22. Canada Fill-Finish Manufacturing Market Share (%), By End-user, 2017-2031F
• Figure 23. Mexico Fill-Finish Manufacturing Market, By Value, in USD Billion, 2017-2031F
• Figure 24. Mexico Fill-Finish Manufacturing Market, By Volume, in Million Units, 2017-2031F
• Figure 25. Mexico Fill-Finish Manufacturing Market Share (%), By Product Type, 2017-2031F
• Figure 26. Mexico Fill-Finish Manufacturing Market Share (%), By Modality, 2017-2031F
• Figure 27. Mexico Fill-Finish Manufacturing Market Share (%), By End-user, 2017-2031F
• Figure 28. Europe Fill-Finish Manufacturing Market, By Value, in USD Billion, 2017-2031F
• Figure 29. Europe Fill-Finish Manufacturing Market, By Volume, in Million Units, 2017-2031F
• Figure 30. Europe Fill-Finish Manufacturing Market Share (%), By Product Type, 2017-2031F
• Figure 31. Europe Fill-Finish Manufacturing Market Share (%), By Modality, 2017-2031F
• Figure 32. Europe Fill-Finish Manufacturing Market Share (%), By End-user, 2017-2031F
• Figure 33. Europe Fill-Finish Manufacturing Market Share (%), By Country, 2017-2031F
• Figure 34. Germany Fill-Finish Manufacturing Market, By Value, in USD Billion, 2017-2031F
• Figure 35. Germany Fill-Finish Manufacturing Market, By Volume, in Million Units, 2017-2031F
• Figure 36. Germany Fill-Finish Manufacturing Market Share (%), By Product Type, 2017-2031F
• Figure 37. Germany Fill-Finish Manufacturing Market Share (%), By Modality, 2017-2031F
• Figure 38. Germany Fill-Finish Manufacturing Market Share (%), By End-user, 2017-2031F
• Figure 39. France Fill-Finish Manufacturing Market, By Value, in USD Billion, 2017-2031F
• Figure 40. France Fill-Finish Manufacturing Market, By Volume, in Million Units, 2017-2031F
• Figure 41. France Fill-Finish Manufacturing Market Share (%), By Product Type, 2017-2031F
• Figure 42. France Fill-Finish Manufacturing Market Share (%), By Modality, 2017-2031F
• Figure 43. France Fill-Finish Manufacturing Market Share (%), By End-user, 2017-2031F
• Figure 44. Italy Fill-Finish Manufacturing Market, By Value, in USD Billion, 2017-2031F
• Figure 45. Italy Fill-Finish Manufacturing Market, By Volume, in Million Units, 2017-2031F
• Figure 46. Italy Fill-Finish Manufacturing Market Share (%), By Product Type, 2017-2031F
• Figure 47. Italy Fill-Finish Manufacturing Market Share (%), By Modality, 2017-2031F
• Figure 48. Italy Fill-Finish Manufacturing Market Share (%), By End-user, 2017-2031F
• Figure 49. United Kingdom Fill-Finish Manufacturing Market, By Value, in USD Billion, 2017-2031F
• Figure 50. United Kingdom Fill-Finish Manufacturing Market, By Volume, in Million Units, 2017-2031F
• Figure 51. United Kingdom Fill-Finish Manufacturing Market Share (%), By Product Type, 2017-2031F
• Figure 52. United Kingdom Fill-Finish Manufacturing Market Share (%), By Modality, 2017-2031F
• Figure 53. United Kingdom Fill-Finish Manufacturing Market Share (%), By End-user, 2017-2031F
• Figure 54. Russia Fill-Finish Manufacturing Market, By Value, in USD Billion, 2017-2031F
• Figure 55. Russia Fill-Finish Manufacturing Market, By Volume, in Million Units, 2017-2031F
• Figure 56. Russia Fill-Finish Manufacturing Market Share (%), By Product Type, 2017-2031F
• Figure 57. Russia Fill-Finish Manufacturing Market Share (%), By Modality, 2017-2031F
• Figure 58. Russia Fill-Finish Manufacturing Market Share (%), By End-user, 2017-2031F
• Figure 59. Netherlands Fill-Finish Manufacturing Market, By Value, in USD Billion, 2017-2031F
• Figure 60. Netherlands Fill-Finish Manufacturing Market, By Volume, in Million Units, 2017-2031F
• Figure 61. Netherlands Fill-Finish Manufacturing Market Share (%), By Product Type, 2017-2031F
• Figure 62. Netherlands Fill-Finish Manufacturing Market Share (%), By Modality, 2017-2031F
• Figure 63. Netherlands Fill-Finish Manufacturing Market Share (%), By End-user, 2017-2031F
• Figure 64. Spain Fill-Finish Manufacturing Market, By Value, in USD Billion, 2017-2031F
• Figure 65. Spain Fill-Finish Manufacturing Market, By Volume, in Million Units, 2017-2031F
• Figure 66. Spain Fill-Finish Manufacturing Market Share (%), By Product Type, 2017-2031F
• Figure 67. Spain Fill-Finish Manufacturing Market Share (%), By Modality, 2017-2031F
• Figure 68. Spain Fill-Finish Manufacturing Market Share (%), By End-user, 2017-2031F
• Figure 69. Turkey Fill-Finish Manufacturing Market, By Value, in USD Billion, 2017-2031F
• Figure 70. Turkey Fill-Finish Manufacturing Market, By Volume, in Million Units, 2017-2031F
• Figure 71. Turkey Fill-Finish Manufacturing Market Share (%), By Product Type, 2017-2031F
• Figure 72. Turkey Fill-Finish Manufacturing Market Share (%), By Modality, 2017-2031F
• Figure 73. Turkey Fill-Finish Manufacturing Market Share (%), By End-user, 2017-2031F
• Figure 74. Poland Fill-Finish Manufacturing Market, By Value, in USD Billion, 2017-2031F
• Figure 75. Poland Fill-Finish Manufacturing Market, By Volume, in Million Units, 2017-2031F
• Figure 76. Poland Fill-Finish Manufacturing Market Share (%), By Product Type, 2017-2031F
• Figure 77. Poland Fill-Finish Manufacturing Market Share (%), By Modality, 2017-2031F
• Figure 78. Poland Fill-Finish Manufacturing Market Share (%), By End-user, 2017-2031F
• Figure 79. South America Fill-Finish Manufacturing Market, By Value, in USD Billion, 2017-2031F
• Figure 80. South America Fill-Finish Manufacturing Market, By Volume, in Million Units, 2017-2031F
• Figure 81. South America Fill-Finish Manufacturing Market Share (%), By Product Type, 2017-2031F
• Figure 82. South America Fill-Finish Manufacturing Market Share (%), By Modality, 2017-2031F
• Figure 83. South America Fill-Finish Manufacturing Market Share (%), By End-user, 2017-2031F
• Figure 84. South America Fill-Finish Manufacturing Market Share (%), By Country, 2017-2031F
• Figure 85. Brazil Fill-Finish Manufacturing Market, By Value, in USD Billion, 2017-2031F
• Figure 86. Brazil Fill-Finish Manufacturing Market, By Volume, in Million Units, 2017-2031F
• Figure 87. Brazil Fill-Finish Manufacturing Market Share (%), By Product Type, 2017-2031F
• Figure 88. Brazil Fill-Finish Manufacturing Market Share (%), By Modality, 2017-2031F
• Figure 89. Brazil Fill-Finish Manufacturing Market Share (%), By End-user, 2017-2031F
• Figure 90. Argentina Fill-Finish Manufacturing Market, By Value, in USD Billion, 2017-2031F
• Figure 91. Argentina Fill-Finish Manufacturing Market, By Volume, in Million Units, 2017-2031F
• Figure 92. Argentina Fill-Finish Manufacturing Market Share (%), By Product Type, 2017-2031F
• Figure 93. Argentina Fill-Finish Manufacturing Market Share (%), By Modality, 2017-2031F
• Figure 94. Argentina Fill-Finish Manufacturing Market Share (%), By End-user, 2017-2031F
• Figure 95. Asia-Pacific Fill-Finish Manufacturing Market, By Value, in USD Billion, 2017-2031F
• Figure 96. Asia-Pacific Fill-Finish Manufacturing Market, By Volume, in Million Units, 2017-2031F
• Figure 97. Asia-Pacific Fill-Finish Manufacturing Market Share (%), By Product Type, 2017-2031F
• Figure 98. Asia-Pacific Fill-Finish Manufacturing Market Share (%), By Modality, 2017-2031F
• Figure 99. Asia-Pacific Fill-Finish Manufacturing Market Share (%), By End-user, 2017-2031F
• Figure 100. Asia-Pacific Fill-Finish Manufacturing Market Share (%), By Country, 2017-2031F
• Figure 101. India Fill-Finish Manufacturing Market, By Value, in USD Billion, 2017-2031F
• Figure 102. India Fill-Finish Manufacturing Market, By Volume, in Million Units, 2017-2031F
• Figure 103. India Fill-Finish Manufacturing Market Share (%), By Product Type, 2017-2031F
• Figure 104. India Fill-Finish Manufacturing Market Share (%), By Modality, 2017-2031F
• Figure 105. India Fill-Finish Manufacturing Market Share (%), By End-user, 2017-2031F
• Figure 106. China Fill-Finish Manufacturing Market, By Value, in USD Billion, 2017-2031F
• Figure 107. China Fill-Finish Manufacturing Market, By Volume, in Million Units, 2017-2031F
• Figure 108. China Fill-Finish Manufacturing Market Share (%), By Product Type, 2017-2031F
• Figure 109. China Fill-Finish Manufacturing Market Share (%), By Modality, 2017-2031F
• Figure 110. China Fill-Finish Manufacturing Market Share (%), By End-user, 2017-2031F
• Figure 111. Japan Fill-Finish Manufacturing Market, By Value, in USD Billion, 2017-2031F
• Figure 112. Japan Fill-Finish Manufacturing Market, By Volume, in Million Units, 2017-2031F
• Figure 113. Japan Fill-Finish Manufacturing Market Share (%), By Product Type, 2017-2031F
• Figure 114. Japan Fill-Finish Manufacturing Market Share (%), By Modality, 2017-2031F
• Figure 115. Japan Fill-Finish Manufacturing Market Share (%), By End-user, 2017-2031F
• Figure 116. Australia Fill-Finish Manufacturing Market, By Value, in USD Billion, 2017-2031F
• Figure 117. Australia Fill-Finish Manufacturing Market, By Volume, in Million Units, 2017-2031F
• Figure 118. Australia Fill-Finish Manufacturing Market Share (%), By Product Type, 2017-2031F
• Figure 119. Australia Fill-Finish Manufacturing Market Share (%), By Modality, 2017-2031F
• Figure 120. Australia Fill-Finish Manufacturing Market Share (%), By End-user, 2017-2031F
• Figure 121. Vietnam Fill-Finish Manufacturing Market, By Value, in USD Billion, 2017-2031F
• Figure 122. Vietnam Fill-Finish Manufacturing Market, By Volume, in Million Units, 2017-2031F
• Figure 123. Vietnam Fill-Finish Manufacturing Market Share (%), By Product Type, 2017-2031F
• Figure 124. Vietnam Fill-Finish Manufacturing Market Share (%), By Modality, 2017-2031F
• Figure 125. Vietnam Fill-Finish Manufacturing Market Share (%), By End-user, 2017-2031F
• Figure 126. South Korea Fill-Finish Manufacturing Market, By Value, in USD Billion, 2017-2031F
• Figure 127. South Korea Fill-Finish Manufacturing Market, By Volume, in Million Units, 2017-2031F
• Figure 128. South Korea Fill-Finish Manufacturing Market Share (%), By Product Type, 2017-2031F
• Figure 129. South Korea Fill-Finish Manufacturing Market Share (%), By Modality, 2017-2031F
• Figure 130. South Korea Fill-Finish Manufacturing Market Share (%), By End-user, 2017-2031F
• Figure 131. Indonesia Fill-Finish Manufacturing Market, By Value, in USD Billion, 2017-2031F
• Figure 132. Indonesia Fill-Finish Manufacturing Market, By Volume, in Million Units, 2017-2031F
• Figure 133. Indonesia Fill-Finish Manufacturing Market Share (%), By Product Type, 2017-2031F
• Figure 134. Indonesia Fill-Finish Manufacturing Market Share (%), By Modality, 2017-2031F
• Figure 135. Indonesia Fill-Finish Manufacturing Market Share (%), By End-user, 2017-2031F
• Figure 136. Philippines Fill-Finish Manufacturing Market, By Value, in USD Billion, 2017-2031F
• Figure 137. Philippines Fill-Finish Manufacturing Market, By Volume, in Million Units, 2017-2031F
• Figure 138. Philippines Fill-Finish Manufacturing Market Share (%), By Product Type, 2017-2031F
• Figure 139. Philippines Fill-Finish Manufacturing Market Share (%), By Modality, 2017-2031F
• Figure 140. Philippines Fill-Finish Manufacturing Market Share (%), By End-user, 2017-2031F
• Figure 141. Middle East & Africa Fill-Finish Manufacturing Market, By Value, in USD Billion, 2017-2031F
• Figure 142. Middle East & Africa Fill-Finish Manufacturing Market, By Volume, in Million Units, 2017-2031F
• Figure 143. Middle East & Africa Fill-Finish Manufacturing Market Share (%), By Product Type, 2017-2031F
• Figure 144. Middle East & Africa Fill-Finish Manufacturing Market Share (%), By Modality, 2017-2031F
• Figure 145. Middle East & Africa Fill-Finish Manufacturing Market Share (%), By End-user, 2017-2031F
• Figure 146. Middle East & Africa Fill-Finish Manufacturing Market Share (%), By Country, 2017-2031F
• Figure 147. Saudi Arabia Fill-Finish Manufacturing Market, By Value, in USD Billion, 2017-2031F
• Figure 148. Saudi Arabia Fill-Finish Manufacturing Market, By Volume, in Million Units, 2017-2031F
• Figure 149. Saudi Arabia Fill-Finish Manufacturing Market Share (%), By Product Type, 2017-2031F
• Figure 150. Saudi Arabia Fill-Finish Manufacturing Market Share (%), By Modality, 2017-2031F
• Figure 151. Saudi Arabia Fill-Finish Manufacturing Market Share (%), By End-user, 2017-2031F
• Figure 152. UAE Fill-Finish Manufacturing Market, By Value, in USD Billion, 2017-2031F
• Figure 153. UAE Fill-Finish Manufacturing Market, By Volume, in Million Units, 2017-2031F
• Figure 154. UAE Fill-Finish Manufacturing Market Share (%), By Product Type, 2017-2031F
• Figure 155. UAE Fill-Finish Manufacturing Market Share (%), By Modality, 2017-2031F
• Figure 156. UAE Fill-Finish Manufacturing Market Share (%), By End-user, 2017-2031F
• Figure 157. South Africa Fill-Finish Manufacturing Market, By Value, in USD Billion, 2017-2031F
• Figure 158. South Africa Fill-Finish Manufacturing Market, By Volume, in Million Units, 2017-2031F
• Figure 159. South Africa Fill-Finish Manufacturing Market Share (%), By Product Type, 2017-2031F
• Figure 160. South Africa Fill-Finish Manufacturing Market Share (%), By Modality, 2017-2031F
• Figure 161. South Africa Fill-Finish Manufacturing Market Share (%), By End-user, 2017-2031F
• Figure 162. By Product Type Map-Market Size (USD Billion) & Growth Rate (%), 2023
• Figure 163. By Modality Map-Market Size (USD Billion) & Growth Rate (%), 2023
• Figure 164. By End-user Map-Market Size (USD Billion) & Growth Rate (%), 2023
• Figure 165. By Region Map-Market Size (USD Billion) & Growth Rate (%), 2023

Global fill-finish manufacturing market is projected to witness a CAGR of 9.17% during the forecast period 2024-2031F, growing from USD 11.74 billion in 2023 to USD 23.68 billion in 2031F. The market has experienced significant growth in recent years and is expected to maintain a strong pace of expansion in the coming years.

Fill-finish manufacturing involves filling medication formulations into primary containers like vials, syringes, cartridges, and bottles. They are then labeled, packaged, and serialized to make them ready for usage and distribution. Fill-finish manufacturing facilities must run effectively, consistently, and at scale to fulfill the increasing demand for pharmaceutical products and guarantee that patients around the world receive high-quality prescriptions on time. Investments in automation technologies, state-of-the-art manufacturing equipment, and process optimization techniques are necessary to increase productivity, reduce downtime, and preserve product quality and safety. Since fill-finish manufacturing activities are the last phases of drug manufacturing before goods are delivered to patients, the growing demand for pharmaceuticals puts great strain on these operations. Globally increasing rates of chronic illness and lifestyle issues are predicted to drive significant growth in the fill-finish manufacturing industry. The substantial expansion of the worldwide biologics industry is driving considerable growth in the fill-finish manufacturing market. Biologics, nowadays are more in demand than conventional medications since they are more efficacious and targeted treatment options. Furthermore, the rise in the fill-finish manufacturing step is being aided by the growing demand for monoclonal antibodies and vaccines. Furthermore, technological advancements act as pillars in the expansion of this market.

For instance, Gerresheimer AG introduced Gx Elite, a range of glass injection vials, in October 2023 to improve and ensure patient safety and production efficiency. This line primarily focuses on providing better-quality vials that are more resistant to shocks, preventing them from breaking quickly.

Rising Healthcare Expenditure to Drive Market Growth

As people increasingly seek medical services and treatments to meet their healthcare needs, the rising healthcare costs can be easily correlated with rising healthcare utilization. Pharmaceutical items are used more frequently to prevent, manage, and treat various medical disorders because of the increasing demand for healthcare services. Consequently, the pharmaceutical industry needs to increase its output to keep up with the growing demand for drugs, fueling the market for fill-finish manufacturing. Globally, the prevalence of chronic illnesses like cancer, diabetes, cardiovascular disease, and respiratory problems is rising, which is driving up the cost of healthcare. Pharmaceutical treatments, such as those for symptom management, disease control, and complication avoidance, are necessary for the long-term management of chronic illnesses. The need for pharmaceutical products is driven by the shift in focus toward managing chronic diseases, which calls for effective fill-finish manufacturing processes to guarantee a consistent supply of medications to patients. The goals of public policy, private sector investments, and international aid activities are to raise healthcare spending, develop access to necessary medical services and prescription drugs, and upgrade healthcare infrastructure in developed and underdeveloped regions. One major factor driving the rise in fill-finish manufacturing is the emergence of novel medicines and specialty drugs. Biologics, orphan drugs, and precision medicines are examples of specialty medications used to treat certain diseases or patient populations with complicated medical demands.

Specific fill-finish manufacturing procedures are frequently needed for these cutting-edge treatments to be stable, effective, and maintain product integrity. To address the demand for specialty drugs, pharmaceutical companies invest in manufacturing capabilities, which propels the fill-finish manufacturing market's growth. For instance, a contract development and manufacturing organization (CDMO) called Recro Pharma, Inc. stated in February 2022 that it had expanded its array of contract manufacturing services to include new lyophilization capabilities. 2,000 pre-sterilized vials could be filled each hour using an automated, sterile vial filling platform in the company's fill-finish aseptic suite. Such healthcare innovation and technological breakthroughs bring new medical devices, diagnostics, and therapies, driving healthcare costs. Novel pharmaceutical products and therapeutic modalities are developed due to advances in drug discovery, genetics, and medical technology, which increases demand for fill-finish manufacturing services. Pharmaceutical firms use technological developments to create novel drugs and formulations that open new growth prospects for the fill-finish manufacturing industry. To stay competitive in the fill-finish manufacturing business, pharmaceutical companies are adjusting to changing regulatory requirements and market situations, which means they are investing more in manufacturing infrastructure and capabilities.

Increasing Demand for Pharmaceuticals Positively Impacts the Market

The global fill-finish manufacturing market is expanding due to the growing demand for pharmaceuticals, influencing industry dynamics and propelling investments in infrastructure, technologies, and skills. Numerous causes, such as population increase, changing demographics, the prevalence of chronic illnesses, and easier access to healthcare services, are contributing to this demand. Industry stakeholders must comprehend how these factors affect pharmaceutical demand, which in turn affects fill-finish manufacturing.

Demographic changes and population expansion are key factors influencing the demand for pharmaceuticals. The demand for pharmaceutical products and healthcare services rises in tandem with the global population. Demand for pharmaceuticals in a variety of therapeutic areas, such as neurological disorders, diabetes, and cardiovascular illnesses, is driven by the fact that elderly people often need more medication to manage age-related health concerns and chronic ailments. Urbanization frequently results in destructive eating patterns, sedentary lifestyles, and greater exposure to environmental toxins, all of which raise the risk of chronic illnesses and necessitate the use of pharmaceutical therapies.

Chronic illnesses, which include autoimmune disorders, cancer, diabetes, respiratory disorders, and cardiovascular diseases, place a significant burden on the world's health and must be managed over time using pharmacological treatments. The rising incidence of chronic illnesses can be attributed to various factors such as aging populations, altered lifestyle patterns, urbanization, and genetic predispositions. Additionally, there is a greater need for pharmacological therapies due to the rising prevalence of chronic illnesses and their identification, as well as improvements in medical technology and screening techniques that raise the incidence of disease detection. Therefore, pharmaceutical companies are pushed further to increase production in order to keep up with the growing demand for drugs that effectively manage chronic illnesses. A major factor in the rising demand for pharmaceuticals is the expansion of healthcare services' accessibility, especially in developing and emerging markets. More access to necessary medications and healthcare services is facilitated by programs like universal health coverage and public health insurance programs, which aim to improve healthcare spending, infrastructure, and coverage. Increasing fill-finish production capacity is one way to guarantee a steady supply of completed dosage forms, such as tablets and capsules injectables, and topical formulations, to meet the needs of diverse patient populations

Since fill-finish manufacturing activities are the last phases of drug manufacture before goods are delivered to patients, the growing demand for pharmaceuticals places a great deal of strain on these operations. Fill-finish manufacturing facilities need to run effectively, consistently, and at scale to fulfill the increasing demand for pharmaceutical products and guarantee that patients around the world receive high-quality prescriptions on time. Investments in automation technologies, state-of-the-art manufacturing equipment, and process optimization techniques are necessary to increase productivity, reduce downtime, and preserve product quality and safety.

Fill-finish manufacturing processes must follow Good Manufacturing Practices (GMP) and other strict regulatory standards to ensure product integrity, safety, and efficacy. Pharmaceutical manufacturers must strictly adhere to regulations to reduce the risks of product contamination, batch failures, and regulatory penalties, which could have serious repercussions for patient safety and public health. Pharmaceutical businesses may also get into strategic alliances, joint ventures, and outsourcing agreements with contract manufacturing organizations (CMOS) in response to growing demand to take advantage of additional manufacturing capacity and knowledge. CMOS specializes in fill-finish manufacturing services, enabling scalability, cost-effectiveness, and flexible production options for pharmaceutical industries.

For example, in February 2024, Simtra BioPharma Solutions stated that it would expand its sterile fill/finish manufacturing campus located in Bloomington, Indiana. A new, state-of-the-art, 150,000-square-foot structure would be built as part of the expansion to run two automated high-speed syringes fill lines and a new high-speed isolator vial line that will have three 30 square meter lyophilizers. By doing this, the company hopes to improve its service skills and draw in additional clients.

Increasing Dominance of Consumables Fuels the Market

Disposable parts used in fill-finish manufacturing processes, such as vials, syringes, cartridges, stoppers, seals, and labels, are included in the consumables segment. In the production of pharmaceuticals, this segment is essential for guaranteeing product integrity, regulatory compliance, and contamination control. Since disposable consumables require less cleaning, sterilizing, and validation compared to reused equipment, they are more affordable. Pharmaceutical businesses frequently prefer disposable components to reduce operating expenses and the risk of contamination. Pharmaceutical firms can adjust production numbers and product configurations in response to market demand and regulatory constraints due to flexible and scalable manufacturing operations made possible by consumables. Disposable consumables make regulatory compliance easier by lowering the possibility of cross-contamination, batch errors, and legal repercussions. Regulatory bodies like the Food and Drug Administration (FDA) and the European Medicines Agency (EMA) advise using disposable components to guarantee product safety and quality. Disposable consumables manufacturers constantly innovate and alter their goods to satisfy changing consumer demands, such as those of specific formulas, package styles, and labeling specifications. Pharmaceutical firms can develop and market their products more flexibly and uniquely when using customizable consumables. All these elements work together to support this segment's expansion.

For example, the EZ-fill Kit and a non-GMP laboratory fill and finish service at its Technology Excellence Centres (TEC), are two new products that Stevanato Group, a global supplier of drug containment and delivery solutions to the pharmaceutical, biotechnology, and life sciences industries, announced on January 24, 2024. By expanding on its current ready-to-use platform of pre-sterilized containment solutions - vials, cartridges, and syringes - Stevanato Group's EZ-fill Kit enables users to screen various primary packaging along with medication items efficiently.

Similarly, in October 2023, Datwyler Holding Inc. launched its ready-for-sterilization (RFS) combi-seals designed for cartridges utilized in injectable devices, including pens and autoinjectors.

Europe to Dominate the Fill-Finish Manufacturing Market

With the most market share in terms of value, Europe emerged as the leading region in the global fill-finish manufacturing market. Europe is known for having a strong regulatory framework that prioritizes product safety, quality, and compliance. To protect the integrity of pharmaceutical manufacturing processes, strict laws and standards, such as Good Manufacturing Practices (GMP), are enforced by regulatory organizations like the European Medicines Agency (EMA) and national regulatory bodies. The Pharmaceutical Strategy for Europe and the Medical Device Regulation (MDR), which were adopted by the European Union, enhance regulatory supervision and encourage fill-finish manufacturing innovation. Following their audits, Nipro Corporation's authorized medical device manufacturers in Europe were able to successfully receive MDR certification in 2022-2023. These certified manufacturers include MTN Neubrandenburg in Germany, Nipro Pure Water (NPW) in Germany, and Nipro Renal Solutions (NRS) in Spain.

Several top pharmaceutical players, academic institutions, and technology providers in the world are based in European nations. These organizations create cutting-edge technologies, automation solutions, and high-quality products to promote innovation in fill-finish manufacturing. Personalized medicine, innovative drug delivery technologies, and biopharmaceuticals are among the areas where Europe excels in fill-finish manufacturing innovation. Europe's extensive logistics and distribution networks also make it easier to manage the global supply chain and distribute pharmaceuticals, which contributes to the region's supremacy in fill-finish production. To improve fill-finish manufacturing skills, European pharmaceutical companies frequently work with academic institutions, CMOs, and technology vendors. Pharmaceutical items have a sizable and varied market in Europe, which presents numerous chances for fill-finish manufacturing businesses to grow and attract new clients.

Fill-finish manufacturing is growing due to the region's advantageous market access conditions, which include reimbursement rules, protection for intellectual property, and adoption of novel therapies by the market. Fill-finish manufacturing enterprises benefit from Europe's dedication to international collaboration and regulatory harmonization. Pharmaceutical products can more easily access international markets thanks to initiatives like the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH), which promotes regulatory standard harmonization. European fill-finish manufacturing businesses can improve their competitiveness in the worldwide market by streamlining their product development, registration, and commercialization procedures by complying with harmonized regulatory norms.

Future Market Scenario (2024-2031F)

One of the main factors contributing to the anticipated growth of the fill-finish manufacturing market is the increasing prevalence of chronic disorders, rising geriatric population and demand for pharmaceuticals. Rising population and sedentary lifestyles are also factors that will always propel market growth in the future. Given that technology is advancing, we can expect cutting-edge technology in this area also. Players in this market are expanding at an unparalleled rate, introducing cost-effective and efficient technologies. For instance, global process and packaging technology company Syntegon Technology GmbH announced in September 2023 that it had unveiled new innovations for the filing and packing of small-micro batches from October 24 to 26, 2023, at CPHI Barcelona, Spain. There is a great demand for equipment made, especially for small batch sizes in research and development and in the manufacturing of liquid and solid medications for sale.

Key Players Landscape and Outlook

Several companies, such as Becton, Dickinson and Company, Nipro Corporation, Syntegon Technology GmbH, Datwyler Holding Inc., Stevanato Group, Recro Pharma, Inc., Gerresheimer AG, West Pharmaceutical Services, Inc., Alcami Corporation, Berry Global Inc., etc., are expanding business by planning and adopting new strategies. They are complying with new strategic initiatives regarding the launch of newly developed fill finish technologies, to help researchers and to strengthen their foothold in the market. New product launches, agreements based on contracts, acquisitions and mergers, investments and partnerships are a few ways in which they are trying to achieve the same.

Contract development and manufacturing organization (CDO), Alcami Corporation, announced on February 8, 2024, the strategic expansion of its sterile fill-finish manufacturing capacity by the addition of a new sterile fill-finish line with isolator and two lyophilizers at its current manufacturing campus in Charleston.

In December 2023, Datwyler Holding Inc. and Conserva UK collaborated to establish a pharmaceutical primary packaging supply chain for the United Kingdom market. By using Conserva UK as the primary interface for its significant client network, this strategic alliance aims to increase Datwyler's presence in the United Kingdom.

Table of Contents

1. Research Methodology

2. Project Scope and Definitions

3. Executive Summary

4. Global Fill Finish Manufacturing Market Outlook, 2017-2031F

• 4.1. Market Size & Forecast
  • 4.1.1. By Value
  • 4.1.2. By Volume
• 4.2. By Product Type
  • 4.2.1. Consumables
    • 4.2.1.1. Vials
      • 4.2.1.1.1. Glass Vials
      • 4.2.1.1.2. Plastic Vials
    • 4.2.1.2. Vial Stoppers
    • 4.2.1.3. Pre-Fillable Syringes
    • 4.2.1.4. Cartridges
    • 4.2.1.5. Others
  • 4.2.2. Instruments
    • 4.2.2.1. By System Type
      • 4.2.2.1.1. Integrated Systems
      • 4.2.2.1.2. Standalone Systems
    • 4.2.2.2. By Machine Type
      • 4.2.2.2.1. Automated Machines
      • 4.2.2.2.2. Semi-Automated Machines
• 4.3. By Modality
  • 4.3.1. Recombinant Proteins
  • 4.3.2. Monoclonal Antibodies
  • 4.3.3. Vaccines
  • 4.3.4. Cell Therapies and Biological Therapies
  • 4.3.5. Gene Therapies
  • 4.3.6. Others
• 4.4. By End-user
  • 4.4.1. Contract Manufacturing Companies
  • 4.4.2. Pharmaceutical and Biopharmaceutical Companies
  • 4.4.3. Others
• 4.5. By Region
  • 4.5.1. North America
  • 4.5.2. Europe
  • 4.5.3. Asia-Pacific
  • 4.5.4. South America
  • 4.5.5. Middle East and Africa
• 4.6. By Company Market Share (%), 2023

5. Global Fill Finish Manufacturing Market Outlook, By Region, 2017-2031F

• 5.1. North America*
  • 5.1.1. Market Size & Forecast
    • 5.1.1.1. By Value
    • 5.1.1.2. By Volume
  • 5.1.2. By Product Type
    • 5.1.2.1. Consumables
      • 5.1.2.1.1. Vials
        • 5.1.2.1.1.1. Glass Vials
        • 5.1.2.1.1.2. Plastic Vials
      • 5.1.2.1.2. Vial Stoppers
      • 5.1.2.1.3. Pre-Fillable Syringes
      • 5.1.2.1.4. Cartridges
      • 5.1.2.1.5. Others
    • 5.1.2.2. Instruments
      • 5.1.2.2.1. By System Type
        • 5.1.2.2.1.1. Integrated Systems
        • 5.1.2.2.1.2. Standalone Systems
      • 5.1.2.2.2. By Machine Type
        • 5.1.2.2.2.1. Automated Machines
        • 5.1.2.2.2.2. Semi-Automated Machines
  • 5.1.3. By Modality
    • 5.1.3.1. Recombinant Proteins
    • 5.1.3.2. Monoclonal Antibodies
    • 5.1.3.3. Vaccines
    • 5.1.3.4. Cell Therapies and Biological Therapies
    • 5.1.3.5. Gene Therapies
    • 5.1.3.6. Others
  • 5.1.4. By End-user
    • 5.1.4.1. Contract Manufacturing Companies
    • 5.1.4.2. Pharmaceutical and Biopharmaceutical Companies
    • 5.1.4.3. Others
  • 5.1.5. United States*
    • 5.1.5.1. Market Size & Forecast
      • 5.1.5.1.1. By Value
      • 5.1.5.1.2. By Volume
    • 5.1.5.2. By Product Type
      • 5.1.5.2.1. Consumables
        • 5.1.5.2.1.1. Vials
        • 5.1.5.2.1.1.1. Glass Vials
        • 5.1.5.2.1.1.2. Plastic Vials
        • 5.1.5.2.1.2. Vial Stoppers
        • 5.1.5.2.1.3. Pre-Fillable Syringes
        • 5.1.5.2.1.4. Cartridges
        • 5.1.5.2.1.5. Others
      • 5.1.5.2.2. Instruments
        • 5.1.5.2.2.1. By System Type
        • 5.1.5.2.2.1.1. Integrated Systems
        • 5.1.5.2.2.1.2. Standalone Systems
        • 5.1.5.2.2.2. By Machine Type
        • 5.1.5.2.2.2.1. Automated Machines
        • 5.1.5.2.2.2.2. Semi-Automated Machines
    • 5.1.5.3. By Modality
      • 5.1.5.3.1. Recombinant Proteins
      • 5.1.5.3.2. Monoclonal Antibodies
      • 5.1.5.3.3. Vaccines
      • 5.1.5.3.4. Cell Therapies and Biological Therapies
      • 5.1.5.3.5. Gene Therapies
      • 5.1.5.3.6. Others
    • 5.1.5.4. By End-user
      • 5.1.5.4.1. Contract Manufacturing Companies
      • 5.1.5.4.2. Pharmaceutical and Biopharmaceutical Companies
      • 5.1.5.4.3. Others
  • 5.1.6. Canada
  • 5.1.7. Mexico

All segments will be provided for all regions and countries covered

• 5.2. Europe
  • 5.2.1. Germany
  • 5.2.2. France
  • 5.2.3. Italy
  • 5.2.4. United Kingdom
  • 5.2.5. Russia
  • 5.2.6. Netherlands
  • 5.2.7. Spain
  • 5.2.8. Turkey
  • 5.2.9. Poland
• 5.3. Asia-Pacific
  • 5.3.1. India
  • 5.3.2. China
  • 5.3.3. Japan
  • 5.3.4. Australia
  • 5.3.5. Vietnam
  • 5.3.6. South Korea
  • 5.3.7. Indonesia
  • 5.3.8. Philippines
• 5.4. South America
  • 5.4.1. Brazil
  • 5.4.2. Argentina
• 5.5. Middle East and Africa
  • 5.5.1. Saudi Arabia
  • 5.5.2. UAE
  • 5.5.3. South Africa

6. Market Mapping, 2023

• 6.1. By Product Type
• 6.2. By Modality
• 6.3. By End-user
• 6.4. By Region

7. Macro Environment and Industry Structure

• 7.1. Demand Supply Analysis
• 7.2. Import Export Analysis
• 7.3. Value Chain Analysis
• 7.4. PESTEL Analysis
  • 7.4.1. Political Factors
  • 7.4.2. Economic System
  • 7.4.3. Social Implications
  • 7.4.4. Technological Advancements
  • 7.4.5. Environmental Impacts
  • 7.4.6. Legal Compliances and Regulatory Policies (Statutory Bodies Included)
• 7.5. Porter's Five Forces Analysis
  • 7.5.1. Supplier Power
  • 7.5.2. Buyer Power
  • 7.5.3. Substitution Threat
  • 7.5.4. Threat From New Entrant
  • 7.5.5. Competitive Rivalry

8. Market Dynamics

• 8.1. Growth Drivers
• 8.2. Growth Inhibitors (Challenges and Restraints)

9. Regulatory Framework and Innovation

• 9.1. Regulatory Approvals
• 9.2. Innovations/Emerging Technologies

10. Key Players Landscape

• 10.1. Competition Matrix of Top Five Market Leaders
• 10.2. Market Revenue Analysis of Top Five Market Leaders (By Value, 2023)
• 10.3. Mergers and Acquisitions/Joint Ventures (If Applicable)
• 10.4. SWOT Analysis (For Five Market Players)
• 10.5. Patent Analysis (If Applicable)

11. Pricing Analysis

12. Case Studies

13. Key Players Outlook

• 13.1. Becton, Dickinson and Company
  • 13.1.1. Company Details
  • 13.1.2. Key Management Personnel
  • 13.1.3. Products and Services
  • 13.1.4. Financials (As Reported)
  • 13.1.5. Key Market Focus and Geographical Presence
  • 13.1.6. Recent Developments
• 13.2. Nipro Corporation
• 13.3. Syntegon Technology GmbH
• 13.4. Datwyler Holding Inc.
• 13.5. Stevanato Group
• 13.6. Recro Pharma, Inc.
• 13.7. Gerresheimer AG
• 13.8. West Pharmaceutical Services, Inc.
• 13.9. Alcami Corporation
• 13.10. Berry Global Inc.

Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work.

14. Strategic Recommendations

15. About Us & Disclaimer